Related Experiment Video
Updated: Feb 11, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase
Frauke Leenders1, Kristin Möpert, Anett Schmiedeknecht
1atugen AG, Berlin, Germany.
Abstract:
Chronic activation of the phosphoinositide 3-kinase (PI3K)/PTEN signal transduction pathway contributes to metastatic cell growth, but up to now effectors mediating this response are poorly defined. By simulating chronic activation of PI3K signaling experimentally, combined with three-dimensional (3D) culture conditions and gene expression profiling, we aimed to identify novel effectors that contribute to malignant cell growth. Using this approach we identified and validated PKN3, a barely characterized protein kinase C-related molecule, as a novel effector mediating malignant cell growth downstream of activated PI3K. PKN3 is required for invasive prostate cell growth as assessed by 3D cell culture assays and in an orthotopic mouse tumor model by inducible expression of short hairpin RNA (shRNA). We demonstrate that PKN3 is regulated by PI3K at both the expression level and the catalytic activity level. Therefore, PKN3 might represent a preferred target for therapeutic intervention in cancers that lack tumor suppressor PTEN function or depend on chronic activation of PI3K.
Insights
Researchers identified PKN3 as a key molecule driving malignant cell growth downstream of phosphoinositide 3-kinase (PI3K) signaling. PKN3 is crucial for invasive prostate cancer growth and may be a therapeutic target in PI3K-dependent cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Chronic activation of the phosphoinositide 3-kinase (PI3K)/PTEN pathway promotes metastatic cell growth.
- Effectors mediating this PI3K-driven malignant growth are not well understood.
Purpose of the Study:
- To identify novel downstream effectors of PI3K signaling that contribute to malignant cell growth.
- To validate the role of identified effectors in cancer progression.
Main Methods:
- Simulated chronic PI3K activation in 3D cell culture models.
- Utilized gene expression profiling to identify novel effectors.
- Validated PKN3 function using 3D cell culture and orthotopic mouse models with shRNA-mediated knockdown.
Main Results:
- Identified and validated PKN3, a protein kinase C-related kinase, as a novel PI3K effector.
- PKN3 is essential for invasive prostate cell growth in vitro and in vivo.
- Demonstrated PI3K regulates PKN3 expression and catalytic activity.
Conclusions:
- PKN3 is a critical mediator of PI3K-driven malignant cell growth.
- PKN3 represents a potential therapeutic target for cancers with dysregulated PI3K signaling, particularly those lacking PTEN function.
Related Concept Videos
Oxygen Requirements and Growth Patterns
Cycloaddition Reactions: MO Requirements for Thermal Activation
Cycloaddition Reactions: MO Requirements for Photochemical Activation
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
The Buckingham Pi Theorem

